Axsome Therapeutics (AXSM)
(Real Time Quote from BATS)
$72.00 USD
-1.08 (-1.48%)
Updated Apr 24, 2024 10:42 AM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/6/24 |
---|---|
Current Quarter | -1.21 |
EPS Last Quarter | -0.73 |
Last EPS Surprise | 39.67% |
ABR | 1.31 |
Earnings ESP
|
-6.90% |
---|---|
Current Year | -3.81 |
Next Year | 0.53 |
EPS (TTM) | -3.27 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 69.81M | 82.37M | 350.08M | 629.76M |
# of Estimates | 6 | 6 | 7 | 7 |
High Estimate | 79.05M | 85.00M | 374.60M | 745.58M |
Low Estimate | 65.70M | 78.67M | 326.03M | 538.95M |
Year ago Sales | 94.58M | 46.70M | 270.60M | 350.08M |
Year over Year Growth Est. | -26.19% | 76.39% | 29.37% | 79.89% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.21 | -1.10 | -3.81 | 0.53 |
# of Estimates | 7 | 6 | 11 | 8 |
Most Recent Consensus | -1.26 | -1.26 | -4.03 | 1.07 |
High Estimate | -0.99 | -0.83 | -1.85 | 4.90 |
Low Estimate | -1.33 | -1.26 | -5.02 | -2.60 |
Year ago EPS | -0.22 | -1.00 | -2.67 | -3.81 |
Year over Year Growth Est. | -450.00% | -10.00% | -42.70% | 113.95% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 0 | 1 | 0 |
Up Last 30 Days | 1 | 0 | 2 | 0 |
Up Last 60 Days | 2 | 1 | 3 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 2 | 2 | 1 |
Down Last 60 Days | 3 | 3 | 3 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.21 | -1.10 | -3.81 | 0.53 |
7 Days Ago | -1.22 | -1.10 | -3.85 | 0.53 |
30 Days Ago | -1.22 | -1.09 | -3.83 | 0.85 |
60 Days Ago | -1.19 | -1.09 | -3.82 | 0.30 |
90 Days Ago | -1.16 | -1.04 | -3.32 | 0.82 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.30 | -1.17 | -4.28 | 1.07 |
Zacks Consensus Estimate | -1.21 | -1.10 | -3.81 | 0.53 |
Earnings ESP | -6.90% | -6.05% | -12.23% | 100.94% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.73 | -1.32 | -1.00 | -0.22 | NA |
Estimate | -1.21 | -1.24 | -1.24 | -1.13 | NA |
Difference | 0.48 | -0.08 | 0.24 | 0.91 | 0.39 |
Surprise | 39.67% | -6.45% | 19.35% | 80.53% | 33.28% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more